Keywords: novartis, completes, sb, antiviral, buy, following, go-ahead

Novartis completes SB antiviral buy

Article | 04 January 2001

Print This

Following the go-ahead for the merger of SmithKline Beecham and GlaxoWellcome (see page 3), Novartis has concluded the acquisition of SB's ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in